Barros, C.d.; Aranha, N.; Severino, P.; Souto, E.B.; Zielińska, A.; Lopes, A.; Rios, A.; Batain, F.; Crescencio, K.; Chaud, M.;
et al. Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration. Pharmaceutics 2021, 13, 686.
https://doi.org/10.3390/pharmaceutics13050686
AMA Style
Barros Cd, Aranha N, Severino P, Souto EB, Zielińska A, Lopes A, Rios A, Batain F, Crescencio K, Chaud M,
et al. Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration. Pharmaceutics. 2021; 13(5):686.
https://doi.org/10.3390/pharmaceutics13050686
Chicago/Turabian Style
Barros, CecÃlia de, Norberto Aranha, PatrÃcia Severino, Eliana B. Souto, Aleksandra ZieliÅ„ska, André Lopes, Alessandra Rios, Fernando Batain, Kessi Crescencio, Marco Chaud,
and et al. 2021. "Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration" Pharmaceutics 13, no. 5: 686.
https://doi.org/10.3390/pharmaceutics13050686
APA Style
Barros, C. d., Aranha, N., Severino, P., Souto, E. B., Zielińska, A., Lopes, A., Rios, A., Batain, F., Crescencio, K., Chaud, M., & Alves, T.
(2021). Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration. Pharmaceutics, 13(5), 686.
https://doi.org/10.3390/pharmaceutics13050686